Clinical evaluation of a combined regenerative technique with enamel matrix derivative, bone grafts, and guided tissue regeneration

International Journal of Periodontics and Restorative Dentistry

Volumn 27, Issue 2, 2007, Pages 171-179

  Harris, Randall J ^a,c   Harris, Laura E ^b   Harris, Christopher R ^c   Harris, Anne J ^c  

^a Private Practice   (United States)

^b UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^c 6591 Breckenridge Court ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENAMEL MATRIX PROTEINS; ENAMEL PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BONE PROSTHESIS; BONE TRANSPLANTATION; EVALUATION; FEMALE; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PERIODONTAL DISEASE; PERIODONTICS; TREATMENT OUTCOME;

ADULT; AGED; BONE SUBSTITUTES; BONE TRANSPLANTATION; COMBINED MODALITY THERAPY; DENTAL ENAMEL PROTEINS; FEMALE; GUIDED TISSUE REGENERATION, PERIODONTAL; HUMANS; MALE; MIDDLE AGED; PERIODONTAL DISEASES; TREATMENT OUTCOME;

EID: 34248231239     PISSN: 01987569     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Heijl L, Heden G, Svardstrom G, Ostgren A. Enamel matrix derivative (Emdogain) in the treatment of intrabony periodontal defects. J Clin Periodontol 1997;24:705-714.
2. Hammarstrom L. Enamel matrix, cementum development and regeneration. J Clin Periodontol 1997;24:658-668.
3. Gestrelius S, Andersson C, Lidstrom D, Hammarstrom L, Somerman M. In vitro studies on periodontal ligament cells and enamel matrix derivative. J Clin Periodontol 1997;24:685-692.
4. Schwartz Z, Carnes DL, Pulliam R, et al. Porcine fetal enamel matrix derivative stimulates proliferative but not differentiation of pre-osteoblastic 2T9 cells, inhibits proliferation and stimulates differentiation of osteoblast-like MG63 cells, and increases proliferation and differentiation of normal human NHOst cells. J Periodontol 2000;71:1287-1296.
5. Van der Pauw MT, Van den Bos T, Everts V, Beertsen W. Enamel matrix-derived protein stimulates attachment of periodontal fibroblasts and enhances alkaline phosphatase activity and transforming growth factor B1 release of periodontal ligament and gingival fibroblasts. J Periodontol 2000;71:31-43.
6. Hoang AM, Oates TW, Cochran DL. In vitro wound healing response to enamel matrix derivative. J Periodontol 2000;71:1270-1277.
7. Ohyama M, Suzuki N, Yamaguchi Y, Maeno M, Otsuka K, Ito K. Effect of enamel matrix derivative on the differentiation of C2C12 cells. J Periodontol 2002;73:543-550.
8. Spahr A, Lyngstadaas SP, Boeckh C, Andersson C, Podbielski A, Haller B. Effect of enamel matrix derivative Emdogain on the growth of periodontal pathogens in vitro. J Clin Periodontol 2002;29:62-72.
9. Zeterstrom O, Andersson C, Eriksson L, et al. Clinical safety of enamel matrix derivative (Emdogain) in the treatment of periodontal defects. J Clin Periodontol 1997;24:697-704.
10. Heden G, Wennstrom J, Lindhe J. Periodontal tissue alterations following Emdogain treatment of periodontal sites with angular bone defects. A series of case reports. J Clin Periodontol 1999;26:855-860.
11. Pontoriero R, Wennstrom J, Lindhe J. The use of barrier membranes and enamel matrix proteins in the treatment of angular bone defects. A prospective controlled clinical study. J Clin Periodontol 1999;26:833-840.
12. Heden G. A case report study of 72 consecutive Emdogain-treated intrabony periodontal defects: Clinical and radiographie findings after 1 year. Int J Periodontics Restorative Dent 2000;20:127-139.
13. Froum S, Weinberg MA, Tarnow D. A comparison study utilizing open flap debridement with and without enamel matrix derivative in the treatment of periodontal intrabony defects - A 12 month re-entry study. J Periodontol 2001;72:25-34.
14. Lekovic V, Camargo PM, Weinlaender M, Nedic M, Aleksic Z, Kenney EB. A comparison between enamel matrix proteins used alone or in combination with bovine porus bone mineral in the treatment of intrabony periodontal defects in humans. J Periodontol 2000;71:1110-1116.
15. Sculean A, Nikolaos D, Blaes A, Lauermann M, Reich E, Brecx M. Comparison of the enamel matrix proteins and bioabsorbable membranes in the treatment of intrabony periodontal defects. A split-mouth study. J Periodontol 1999;70:255-262.
16. Sculean A, Blaes A, Arweiler N, Reich E, Nikolaos D, Brecx M. The effect of postsurgical antibiotics on the healing of intrabony defects following treatment with enamel matrix proteins. J Periodontol 2001;72:190-195.
17. Windisch P, Sculean A, Klein F, et al. Comparison of clinical, radiographic, and histometric measurements following treatment with guided tissue regeneration or enamel matrix proteins in human periodontal defects. J Periodontol 2002; 73:409-417.
18. Zucchelli G, Bernardi F, Montebugnoli L, De Sanctis M. Enamel matrix proteins and guided tissue regeneration with titanium-reinforced expanded polytetrafluoroethylene membranes in the treatment of infrabony defect: A comparative controlled clinical trial. J Periodontol 2002;73:3-12.
19. Cardaropoli G, Leonhardt AS. Enamel matrix proteins in the treatment of deep intrabony defects. J Periodontol 2002;73:501-504.
20. Velasquez-Plata D, Scheyer ET, Mellonig JT. Clinical comparison of an enamel matrix derivative used alone or in combination with a bovine-derived xenograft for the treatment of periodontal osseous defects in humans. J Periodontol 2002;73:433-440.
21. Scheyer ET, Velasquez-Plata D, Brunsvold MA, Lasho DJ, Mellonig JT. A clinical comparison of a bovine-derived xenograft used alone and in combination with enamel matrix derivative for the treatment of periodontal osseous defects in humans. J Periodontol 2002;73:423-432.
22. Sculean A, Chiantella GC, Windisch P, Gera I, Reich E. Clinical evaluation of an enamel matrix protein derivative (Emdogain) combined with a bovine-derived xenograft (Bio-Oss) for the treatment of intrabony periodontal defects humans. Int J Periodontics Restorative Dent 2002;22:259-267.
23. Lekovic V, Camargo PM, Weinlaender M, Kenney EB, Vasilic N. Combination use of bovine porus bone mineral, enamel matrix proteins, and a bioabsorbable membrane in intrabony periodontal defects in humans. J Periodontol 2001;72:583-589.
24. Froum S, Lemler J, Horowitz R, Davidson B. The use of enamel matrix derivative in the treatment of periodontal osseous defects: A clinical decision tree based on biologic principles of regeneration. Int J Periodontics Restorative Dent 2001;21:437-449.
25. Spence J, Cotton J, Underwood B, Duncan C. Elementary Statistics. Englewood Cliffs, NJ: Prentice-Hall, 1983:145-195.
26. Cortellini P, Tonetti MS. Focus on intrabony defects: Guided tissue regeneration. Periodontol 2000 2000;22:104-132.
27. Rosen PS, Reynolds MA, Bowers GM. The treatment of intrabony defects with bone grafts. Periodontol 2000 2000;22:88-103.
28. Garrett S. Periodontal regeneration around natural teeth. Ann Periodontol 1996;1:621-666.